PASG
Passage Bio Inc
NASDAQ: PASG · HEALTHCARE · BIOTECHNOLOGY
$5.11
-4.49% today
Updated 2026-04-30
Market cap
$18.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.35
Dividend yield
—
52W range
$5 – $20
Volume
0.1M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$11.40
+123.09%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-6.48M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-136.13M | $-102.06M | $-64.77M | $-45.52M | $-12.98M |
| EPS | — | — | — | — | $-14.35 |
| Free cash flow | $-123.48M | $-78.41M | $-47.99M | $-31.51M | $-6.48M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Passage Bio Inc trades at $5.11. Our Smart Value Score of 30/100 indicates the stock is weak.
Frequently asked questions
What is Passage Bio Inc's stock price?
Passage Bio Inc (PASG) trades at $5.11.
Is Passage Bio Inc overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell).
What is the price target of Passage Bio Inc (PASG)?
The analyst target price is $11.40, representing +123.1% upside from the current price of $5.11.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-113.80%
Beta1.77
50D MA$8.27
200D MA$8.64
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—